These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 667867)
1. Systolic time intervals: an effective measure of cardiac function in anthracycline-induced cardiomyopathy of rabbits. Long HJ Cancer Treat Rep; 1978 Jun; 62(6):911-4. PubMed ID: 667867 [TBL] [Abstract][Full Text] [Related]
2. Systolic time intervals in monitoring for anthracycline cardiomyopathy in pediatric patients. Hutchinson RJ; Bailey C; Wood D; Donaldson MH Cancer Treat Rep; 1978 Jun; 62(6):907-10. PubMed ID: 667866 [TBL] [Abstract][Full Text] [Related]
3. Noninvasive polygraphic cardiac changes in daunorubicin-induced cardiomyopathy in rabbits. Gersl V; Hrdina R Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1994; 37(2):49-55. PubMed ID: 7784798 [TBL] [Abstract][Full Text] [Related]
4. Invasive and noninvasive methods of assessing adriamycin cardiotoxic effects in man: superiority of histopathologic assessment using endomyocardial biopsy. Mason JW; Bristow MR; Billingham ME; Daniels JR Cancer Treat Rep; 1978 Jun; 62(6):857-64. PubMed ID: 667859 [TBL] [Abstract][Full Text] [Related]
5. Systolic time interval recordings in rabbits with congestive cardiomyopathy induced by chronic anthracycline administration. Long HJ; Diamond SS; Burningham RA; Raflo CP Am J Vet Res; 1983 Jul; 44(7):1375-7. PubMed ID: 6576659 [TBL] [Abstract][Full Text] [Related]
6. Adriamycin cardiotoxicity: early detection by systolic time interval and possible prevention by coenzyme Q10. Cortes EP; Gupta M; Chou C; Amin VC; Folkers K Cancer Treat Rep; 1978 Jun; 62(6):887-91. PubMed ID: 667863 [TBL] [Abstract][Full Text] [Related]
7. [Pharmacokinetics and acute signs of cardiac toxicity during doxorubicin therapy]. Lenzhofer R; Schneeweiss B; Rameis H; Eichler H; Graninger W; Dittrich C; Dudczak R; Ganzinger U; Gasic S; Moser K Wien Klin Wochenschr; 1983 Jan; 95(2):52-5. PubMed ID: 6858169 [TBL] [Abstract][Full Text] [Related]
8. Anthracycline cardiomyopathy monitored by morphologic changes. Billingham ME; Mason JW; Bristow MR; Daniels JR Cancer Treat Rep; 1978 Jun; 62(6):865-72. PubMed ID: 667860 [TBL] [Abstract][Full Text] [Related]
10. Noninvasive profile in the prospective monitoring of adriamycin cardiomyopathy. Fulkerson PK; Talley R; Kleinman D; Weaver SK; Leier CV; Balcerzak SP; Lewis RP Cancer Treat Rep; 1978 Jun; 62(6):881-6. PubMed ID: 667862 [No Abstract] [Full Text] [Related]
11. Systolic time interval recordings as a measure of cardiac function in the healthy rabbit: reference values. Long HJ; Diamond SS; Burningham RA; Raflo CP Am J Vet Res; 1982 Aug; 43(8):1497-9. PubMed ID: 7103236 [TBL] [Abstract][Full Text] [Related]
12. [Noninvasive cardia fúnction diagnosis in children treated with adriamycin (author's transl)]. Schmaltz AA; Treuner J; Class U; Heil RP Klin Padiatr; 1980 Nov; 192(6):502-8. PubMed ID: 7194391 [TBL] [Abstract][Full Text] [Related]
13. Systolic time intervals in monitoring adriamycin-induced cardiotoxicity. Balcerzak SP; Christakis J; Lewis RP; Olson HM; Malspeis L Cancer Treat Rep; 1978 Jun; 62(6):893-9. PubMed ID: 667864 [No Abstract] [Full Text] [Related]
14. The interval-force relationship: a technique for evaluating the cardiac toxicity of anthracycline analogs. Breed JG; Zimmerman AN; Meyler FL; Pinedo HM Cancer Treat Rep; 1979 May; 63(5):869-73. PubMed ID: 455328 [TBL] [Abstract][Full Text] [Related]
15. Comparative analysis of noninvasive cardiac parameters in the detection and evaluation of adriamycin cardiotoxicity. Shuman RD; Ettinger DS; Abeloff MD; Livengood SV; Fortuin NJ Johns Hopkins Med J; 1981 Aug; 149(2):57-63. PubMed ID: 7253365 [TBL] [Abstract][Full Text] [Related]
16. Serum carnitine levels during the doxorubicin therapy. Its role in cardiotoxicity. Yaris N; Ceviz N; Coskun T; Akytüz C; Büyükpamukçu M J Exp Clin Cancer Res; 2002 Jun; 21(2):165-70. PubMed ID: 12148572 [TBL] [Abstract][Full Text] [Related]
17. Clinical evaluation of the cardiac toxicity of 4'-deoxy-doxorubicin. Villani F; Galimberti M; Comazzi R; Crippa F; Bonfante V; Ferrari L; Pacciarini MA Int J Clin Pharmacol Ther Toxicol; 1988 Apr; 26(4):185-9. PubMed ID: 3403095 [TBL] [Abstract][Full Text] [Related]
18. Influence of carnosine on the cardiotoxicity of doxorubicin in rabbits. Zieba R; Wagrowska-Danilewicz M Pol J Pharmacol; 2003; 55(6):1079-87. PubMed ID: 14730104 [TBL] [Abstract][Full Text] [Related]
19. Reduction of the cardiotoxicity of doxorubicin in rabbits and dogs by encapsulation in long-circulating, pegylated liposomes. Working PK; Newman MS; Sullivan T; Yarrington J J Pharmacol Exp Ther; 1999 May; 289(2):1128-33. PubMed ID: 10215696 [TBL] [Abstract][Full Text] [Related]